IRIS
SAMBATARO, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.926
AS - Asia 884
SA - Sud America 385
EU - Europa 247
AF - Africa 21
OC - Oceania 1
Totale 3.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.873
SG - Singapore 345
HK - Hong Kong 339
BR - Brasile 329
IE - Irlanda 81
VN - Vietnam 68
TR - Turchia 42
IT - Italia 40
GB - Regno Unito 32
DE - Germania 29
CA - Canada 22
AR - Argentina 21
MX - Messico 18
BD - Bangladesh 17
IN - India 16
EC - Ecuador 10
ES - Italia 10
JP - Giappone 10
ID - Indonesia 9
NL - Olanda 8
RU - Federazione Russa 8
ZA - Sudafrica 8
CO - Colombia 7
FR - Francia 7
PL - Polonia 7
UA - Ucraina 7
AT - Austria 6
IQ - Iraq 6
VE - Venezuela 6
PY - Paraguay 5
EG - Egitto 4
MA - Marocco 4
PE - Perù 4
PK - Pakistan 4
QA - Qatar 4
SA - Arabia Saudita 4
SE - Svezia 4
HN - Honduras 3
KZ - Kazakistan 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
CN - Cina 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
FI - Finlandia 2
JO - Giordania 2
LT - Lituania 2
OM - Oman 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
Totale 3.464
Salva come PNG Salva come JPEG
Città #
Dallas 1.398
Hong Kong 339
Santa Clara 123
Singapore 103
Dublin 81
The Dalles 73
Istanbul 34
Ashburn 29
Ho Chi Minh City 27
São Paulo 23
New York 21
Assago 20
Los Angeles 19
Hanoi 14
Rio de Janeiro 13
Belo Horizonte 10
Montreal 10
San Francisco 10
Düsseldorf 9
Mexico City 9
Tokyo 9
Brasília 8
Brooklyn 7
Manchester 7
Seattle 6
Toronto 6
Warsaw 6
Atlanta 5
Curitiba 5
Denver 5
Dhaka 5
Johannesburg 5
London 5
Porto Alegre 5
Ankara 4
Boston 4
Camaçari 4
Catania 4
Charlotte 4
Doha 4
Fortaleza 4
Frankfurt am Main 4
Guayaquil 4
Lauterbourg 4
Lima 4
Maceió 4
Phoenix 4
Stockholm 4
São Bernardo do Campo 4
Thái Bình 4
Campinas 3
Caxias do Sul 3
Chennai 3
Chicago 3
Cuiabá 3
Jakarta 3
Joinville 3
Limeira 3
Manaus 3
Moscow 3
Portsmouth 3
Ribeirão Preto 3
Rio Grande 3
Santo André 3
Vienna 3
Addis Ababa 2
Amman 2
Anápolis 2
Aracaju 2
Asunción 2
Baghdad 2
Barra Mansa 2
Biên Hòa 2
Bogotá 2
Buenos Aires 2
Cachoeirinha 2
Caracas 2
Cariacica 2
Casablanca 2
Chaguanas 2
Cincinnati 2
Cleveland 2
Criciúma 2
Erbil 2
Giza 2
Goiânia 2
Guarulhos 2
Helsinki 2
Ilhéus 2
Itatiba 2
Ituiutaba 2
Jeddah 2
La Plata 2
Lahore 2
Medellín 2
Medianeira 2
Miami 2
Mobile 2
Montevideo 2
Mumbai 2
Totale 2.628
Salva come PNG Salva come JPEG
Nome #
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 58
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 54
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study 53
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis from the CLASS project 50
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 49
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 48
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 46
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 46
Radiological Insights into UIP Pattern: A Comparison Between IPF and Non-IPF Patients 45
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 44
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 43
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 43
Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group 42
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 42
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 42
Autoimmunity in interstitial lung disease 42
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 41
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 41
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 41
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project 40
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 39
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 39
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study 39
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 38
A die-hard giant capillary 38
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 38
COVAD survey 2 long-term outcomes: unmet need and protocol 37
Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases 37
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 37
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 37
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 36
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey 34
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 33
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course 33
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 33
Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply 33
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study 31
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 31
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 31
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 31
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 31
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 30
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 30
Pulmonary vasculitides: A radiological review emphasizing parenchymal hrct features 30
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 29
Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes 29
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 29
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 29
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 28
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? 28
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 28
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 28
Quantitative evaluation of fibrosis in ipf patients: Meaning of diffuse pulmonary ossification 27
Experience of a second-level rheumatology clinic during the COVID-19 quarantine 27
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 27
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 26
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 26
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: Results from the COVAD study 26
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 25
Developing PI3K Inhibitors for Respiratory Diseases 25
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases 25
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 25
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 25
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 25
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 24
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 24
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: A comparative analysis of the COVAD surveys 24
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 24
Pleural Irregularities: A new ultrasound marker for lung involvement in primary Sjögren's disease 24
Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review 24
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 24
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives 24
The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 24
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 24
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 23
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 23
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? 23
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 23
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 23
Eosinophilic Interstitial Pneumonia 23
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 23
Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected Patients 23
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 23
“Usual” interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 22
The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: A validation study of the NEMO score 22
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis 22
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys 22
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study 22
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 22
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 22
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 22
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 22
COVID-19-Induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: Hypothesis regarding mechanism of intestinal damage associated with COVID-19 22
Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health 22
Quantitative chest tomography indexes are related to disease activity in systemic sclerosis: results from a cross-sectional study 22
Hepatic PPARs: Their role in liver physiology, fibrosis and treatment 21
Highlights on Future Treatments of IPF: Clues and Pitfalls 21
High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis 21
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 21
Heart Valve Abnormalities in Systemic Sclerosis Patients; A Multicenter Cohort Study and Review of the Literature 21
Totale 3.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.523 0 0 0 0 334 287 113 127 156 189 203 114
2025/20262.090 214 941 719 216 0 0 0 0 0 0 0 0
Totale 3.613